What happened
Immediate 14-day wearable ECG monitoring failed to reduce syncope episodes at one year versus standard practice, but more than doubled arrhythmia detection, halved time to diagnosis and was associated with a 50% reduction in mortality.
Edited by Matthew J. Reed, an author
Author’s note
The ASPIRED trial showed that early prolonged ECG monitoring in patients presenting to the ED with unexplained syncope failed to reduce syncope episodes at one year versus standard practice but more than doubled arrhythmia detection, halved time to diagnosis and was associated with a 50% reduction in mortality.
Matthew J. Reed · Shared on Synapse
“Although immediate ECG monitoring did not reduce recurrent fainting, it enabled earlier identification of serious cardiac rhythm disorders, allowing patients to receive treatment much sooner, reducing uncertainty and anxiety, and potentially preventing avoidable deaths.”
Dr. Matthew J. Reed
The abstract is misleading because it leads with the null syncope result and plays down a one-year mortality reduction.
X post ↗
Don't wait after unexplained syncope. Early 14-day monitoring should be strongly considered for diagnosis.
X post ↗
The monitor did not cut syncope burden, but it identified high-risk patients and halved all-cause mortality.
X post ↗
Early monitoring finds actionable arrhythmias, with detection at 22% vs 9% and mortality at 1.5% vs 2.9%.
X post ↗
“Among patients with syncope that remained unexplained after evaluation in the emergency department, the use of 14-day ambulatory ECG monitoring did NOT result in significantly fewer patient-reported syncope episodes at 1 year than standard care.”
X ↗Mohammed Al-Qadami
“In 2,234 patients with unexplained syncope, early 14-day ECG monitoring did not reduce recurrence, but increased clinically significant arrhythmia detection (22% vs 9%) and enabled earlier treatment.”
X ↗Open questions from this trial that would benefit from expert input.
Answers are grounded in this paper and cite their sources.
Why the trial, tables, limitations, PICO, abstract, media & sources
Unexplained syncope often goes undiagnosed for months under standard monitoring, delaying treatment of underlying arrhythmias. ASPIRED asked whether immediate enhanced ambulatory ECG monitoring shortens the time to diagnosis and improves management.
Does 14-day ambulatory ECG monitoring reduce patient-reported episodes of syncope in adults with unexplained syncope after emergency department evaluation?
| Outcome | 14-day ECG | Standard |
|---|---|---|
| Patient-reported syncope episodes at 1 year (mean) Primary · IRR 0.89 (95% CI 0.68–1.18; p=0.42) — no significant reduction | 14-day ECG 1.37 | Standard 1.58 |
| Arrhythmia detection From the trial record; not reported in the publication abstract | 14-day ECG 22% | Standard 9% |
| All-cause mortality From the trial record, not the abstract · hypothesis-generating only | 14-day ECG 1.5% | Standard 2.9% |
Does 14-day ambulatory ECG monitoring reduce patient-reported episodes of syncope in adults with unexplained syncope after emergency department evaluation?
Initiating 14-day ambulatory ECG monitoring in patients with unexplained syncope in the emergency department increased the detection of clinically relevant arrhythmias but did not reduce patient-reported syncope recurrences at 1 year.
Experts accept that immediate heart-rhythm monitoring after unexplained fainting did not prevent repeat faints, but most read the trial as a win for early monitoring because it found more arrhythmias and was linked to lower mortality.
Clinicians posting about ASPIRED mostly look past the flat primary result. They focus on faster diagnosis and fewer deaths in the monitored group, and one calls the abstract's framing misleading. The open question is whether emergency department syncope pathways will move to early monitoring on the strength of those findings.
Several clinicians say the main finding is not the lack of fewer faints. They point instead to lower all-cause mortality with early monitoring.
Suliman says ASPIRED may change emergency department syncope pathways, but none of the posts say whether guidelines or local practice will change. No one discussed how much weight the mortality result can carry when the primary endpoint was neutral.
Does not support routine 14-day monitoring to reduce syncope recurrences; challenges assumptions from smaller studies on early monitoring benefits.
BackgroundIn patients with syncope who present to the emergency department for evaluation, diagnosing an underlying cardiac arrhythmia remains difficult. MethodsWe conducted an open-label, randomized, controlled trial at 45 hospitals in the United Kingdom to assess the effects of 14-day cardiac monitoring on diagnosis, treatment, and outcomes among patients with syncope. Adults with syncope that remained unexplained after an evaluation in the emergency department were assigned in a 1:1 ratio to undergo 14-day ambulatory electrocardiographic (ECG) monitoring (the intervention group) or to receive the standard care provided for patients with unexplained syncope at each participating site (the standard-care group). The primary outcome was the mean number of patient-reported episodes of syncope at 1 year. ResultsA total of 2234 patients underwent randomization: 1123 were assigned to the intervention group and 1111 to the standard-care group. The mean age of the patients was 58.3 years, and 52.1% were male. After the exclusion of patients who did not complete any follow-up, a total of 1970 patients (1004 in the intervention group and 966 in the standard-care group) were included in the primary analysis. The mean (±SD) number of patient-reported syncope episodes at 1 year was 1.37±5.10 in the intervention group and 1.58±8.56 in the standard-care group (incidence rate ratio, 0.89; 95% confidence interval, 0.68 to 1.18; P=0.42). A total of 49 adverse events were reported in the intervention group, and 8 adverse events were reported in the standard-care group, with 1 serious adverse event in each group. ConclusionsAmong patients with syncope that remained unexplained after evaluation in the emergency department, the use of 14-day ambulatory ECG monitoring did not result in significantly fewer patient-reported syncope episodes at 1 year than standard care. (Funded by the British Heart Foundation and National Health Service Research Scotland; ASPIRED ISRCTN Registry number, ISRCTN10278811.)
Reed et al. (2026) conducted an RCT in Unexplained syncope (n=2,234). 14-day ambulatory electrocardiographic (ECG) monitoring vs. Standard care was evaluated on Mean number of patient-reported episodes of syncope at 1 year (IRR 0.89, 95% CI 0.68 to 1.18, p=0.43). 14-day ambulatory ECG monitoring did not reduce the mean number of self-reported syncope episodes at 1 year compared to standard care in patients with unexplained syncope.
Synapse has enriched 10 related papers. Consider them for comparative context: